Status:

NOT_YET_RECRUITING

Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Crohn Disease

Functional Gastrointestinal Disorders

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to compare the gastro-intestinal biopotentials recorded with a homemade device using surface electrodes placed on the abdomen in healthy volunteers, Crohn's disease ...

Detailed Description

Diseases and disorders of the digestive tract affect a large proportion of the world's population. These disorders or diseases degrade patients' quality of life and are costly for healthcare systems. ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for all participants:
  • Person age \> 18 years
  • Person has been fasting for at least 12 hours
  • Person who has received full information on the organization of the research and has not objected to the use of this data.
  • Person affiliated to or beneficiary of a social security plan
  • Person informed about study organization and having signed the informed consent
  • Inclusion Criteria for healthy volunteers :
  • Person has no history of chronic gastro-intestinal disease
  • Person has no acute of gastro-intestinal disease
  • Inclusion Criteria for Crohn's disease patients without fibrosis :
  • Person is already diagnosed with Crohn's disease
  • Person has underwent during the last 6 months :
  • An MRI showing no fibrosis
  • A blood test for C-reactive protein and fecal calprotectine
  • A questionnaire to asses the Harvey-Bradshaw Index
  • Inclusion Criteria for Crohn's disease patients with fibrosis :
  • Person is already diagnosed with Crohn's disease
  • Person has underwent during the last 6 months :
  • An MRI showing fibrosis
  • A blood test for C-reactive protein and fecal calprotectine
  • A questionnaire to asses the Harvey-Bradshaw Index
  • Inclusion Criteria for functional gastrointestinal disorders patients :
  • Person is already diagnosed with functional gastrointestinal disorders
  • Person has underwent an evaluation of the Rome IV criteria
  • Exclusion Criteria for all participants:
  • Person having a pacemaker
  • Person suffering from a sensory disorder making insensitive to pain on the skin
  • Person suffering from a mental or motor disorders creating uncontroled movements
  • Person being allergic to one or more component of the device
  • Person being allergic to : soy, dairy food, peanuts, wheat, nuts
  • Person having an history of gastro-intestinal surgery
  • Person suffering from injury or erythema on the abdominal skin
  • Person having a contagious potential (bacterial, fungal or viral)
  • Person being in menstruation period
  • Person suffering from urinary incontinence
  • Minor (not emancipated)
  • Person of legal age (subject to a legal protection measure)
  • Adult unable to give consent

Exclusion

    Key Trial Info

    Start Date :

    March 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2025

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06197334

    Start Date

    March 1 2024

    End Date

    September 1 2025

    Last Update

    January 9 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CHRU de Nancy - Brabois

    Vandœuvre-lès-Nancy, France, 54500